Cardiology Discovery

Aims & Scope

Cardiology Discovery (CD) is the official journal of the Chinese Society of Cardiology (CSC) of Chinese Medical Association (CMA).

It is an English language, peer-reviewed journal aims to publish high-quality materials on all aspects of cardiovascular medicine and surgery, including original clinical, epidemiological, basic and translational research, health services and outcomes studies, state-of-the-art reviews, technical evaluations, case reports, editorial, perspective, consensus and guideline papers.

CD has a international outlook, that is to create a platform of international collaboration and exchange of cutting-edge information on cardiovascular research and education.

Articles are published quarterly.

The journal is available both in print and online.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Long-term Management of Patients with Myocardial Infarction: An Updated Review

  Citation: 11

  Authors: Runzhen, Hanjun, Hongbing

• Interpretation of the Annual Report on Cardiovascular Health and Diseases in China 2020

  Citation: 10

  Authors:

• Emerging Treatment Approaches to Improve Outcomes in Patients with Heart Failure

  Citation: 6

  Authors: Barry H.

• Lipoprotein(a) and Atherosclerotic Cardiovascular Diseases: Evidence from Chinese Population

  Citation: 5

  Authors: Jianjun

• Interpretation of the Annual Report on Cardiovascular Health and Diseases in China 2021

  Citation: 4

  Authors:

• A Review of Double Kissing Crush Stenting in Coronary Bifurcation Lesions

  Citation: 4

  Authors: Tak W., Patricia

• Rationale and Design of a Randomized Controlled Trial of Bivalirudin with a Prolonged High-Dose Infusion Versus Heparin Monotherapy During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction: The BRIGHT-4 Trial

  Citation: 3

  Authors: Zhenyang, Yi, Gregg W., Yaling

• Chinese Guidelines for the Diagnosis and Management of Atrial Fibrillation

  Citation: 3

  Authors:

• Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2024

  Citation: 3

  Authors:

• Interpretation of the Annual Report on Cardiovascular Health and Diseases in China 2022

  Citation: 2

  Authors: